July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
UVR-B-induced NKR-1 expression in ocular tissues is blocked by spantide I in exposed and partner eye
Author Affiliations & Notes
  • Janine Groß
    Ophthalmology, University of Bonn, Bonn, Germany
  • Alfred R Wegener
    Ophthalmology, University of Bonn, Bonn, Germany
  • Frank G. Holz
    Ophthalmology, University of Bonn, Bonn, Germany
  • Martin Kronschlaeger
    Department of Ophthalmology, Hanusch Hospital, Vienna, Austria
  • Carl-Ludwig Schoenfeld
    Herzog Carl Theodor Eye Clinic, Munich, Germany
    Ludwig-Maximilians-University Munich, Munich, Germany
  • Linda Meyer
    Ophthalmology, University of Bonn, Bonn, Germany
    Herzog Carl Theodor Eye Clinic, Munich, Germany
  • Footnotes
    Commercial Relationships   Janine Groß, None; Alfred Wegener, None; Frank Holz, Acucela (F), Acucela (C), Alcon (F), Allergan (F), Allergan (C), Bayer HealthCare (F), Bayer HealthCare (C), Boehringer Ingelheim (C), Carl Zeiss Meditec (F), Genentech/Roche (F), Genentech/Roche (C), Heidelberg Engineering (F), Heidelberg Engineering (C), Heidelberg Engineering (R), Merz (C), Novartis (F), Novartis (C), Optos (F); Martin Kronschlaeger, None; Carl-Ludwig Schoenfeld, None; Linda Meyer, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3036. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Janine Groß, Alfred R Wegener, Frank G. Holz, Martin Kronschlaeger, Carl-Ludwig Schoenfeld, Linda Meyer; UVR-B-induced NKR-1 expression in ocular tissues is blocked by spantide I in exposed and partner eye. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3036.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate UVR-B-induced NKR-1 expression in ocular tissues before and after treatment with substance P receptor antagonist, spantide I in exposed as well as non-exposed partner eyes.

Methods : Six-week-old C57Bl/6 mice were injected intraperitoneally with 36 µg/mouse of spantide I before and after UVR-B exposure. Control mice were similarly injected with saline only. Pretreated mice were unilaterally exposed to a 5-fold cataract threshold dose (1.45 J/cm2) of UVR-B (UVR-B peak at 312nm) with a Bio-Spectra system. Three, seven, and 14 days post exposure, eyes were fixed, embedded in paraffin, sectioned and stained with a fluorescence coupled antibody for substance P receptor (NKR-1) and DAPI staining. The same was performed in animals receiving only pretreatment and anaesthesia but no UVR-exposure. NKR-1 protein levels in ocular tissue lysates of exposed and contralateral eyes were quantified by immunofluorescence and enzyme-linked immunosorbent assay (ELISA).

Results : UVR-B exposure induces an NKR-1 upregulation in ocular tissues of exposed and contralateral eyes. Three days after UVR-B exposure NKR-1 immunoreactivity decreased in animals treated with spantide I in the exposed and contralateral cornea, iris and retina, in comparison to the control group. After an initial blocking of NKR-1 at day 3, NKR-1 is overexpressed 7 days post-exposure in the UVR-irradiated as well as the partner eye after spantide I treatment.

Conclusions : The UVR-B induced expression of substance P receptor, NKR-1 in ocular tissues is affected by spantide I in the exposed as well as in the unexposed partner eye. SP might be the signaling molecule involved in the contralateral reaction following unilateral UVR-B exposure.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×